The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007
Allergen-induced nonspecific bronchial hyperresponsiveness in patients with intermittent asthma Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009
The role of CCR5 in allergen-induced airway hyperresponsiveness and airway inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009
Is atopy an important factor of bronchial hyperresponsiveness in asthmatic patients? Source: Eur Respir J 2001; 18: Suppl. 33, 368s Year: 2001
IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 104s Year: 2003
Increased airway closure is a determinant of airway hyperresponsiveness Source: Eur Respir J 2008; 32: 1563-1569 Year: 2008
Influence of endogenous corticosteroids on bronchial protective properties of β2 -agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010
Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001
Small airways involvement is associated with bronchial hyperresponsiveness in asthma Source: Annual Congress 2012 - Different ways to phenotype asthma Year: 2012
Correlation between bronchial hyperresponsiveness and bronchial inflammation in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002
Functional activity of bronchial neutrophils in the patients with cold airway hyperresponsiveness (CAHR) in severe asthma Source: International Congress 2017 – Translational studies of lung disease Year: 2017
Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018
The burden of airway hyperresponsiveness on the control of asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011
Markers of airway inflammation and airway hyperresponsiveness remain stable in untreated asthmatics over time Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
The influence of smoking on the formation of cold airway hyperresponsiveness and destructive-cytolytic profile of goblet cells in asthma patients Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018
Use of leikotriene modifiers promotes to decrease bronchial hyperreactivity in bronchial asthma patients Source: Annual Congress 2012 - Asthma management Year: 2012
Cholinergic tone and airway hyperresponsiveness in patients with persistent allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 219s Year: 2006
Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014
Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007
Sputum eosinophilia, airway hyperresponsiveness and airway narrowing in young adults with former asthma Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005